Rachel Lenington serves as a member of the Board of Directors at Global Health Labs (GH Labs). Currently, she is the Chief Operating Officer at Athira Pharma, where she leads strategy and operations to deliver on the organization’s mission and growth.

Prior to Athira, Rachel spent over twenty years in life sciences working across a variety of therapeutic areas and phases of development from pre-IND through commercialization. At leading biotech companies including Amgen and Seagen, Rachel played an instrumental role in multiple global approvals and launches for Prolia®, ADCETRIS®, PADCEV®, and TUKYSA®.

Previously, she worked at the Bill & Melinda Gates Foundation leading strategy and business operations for global health programs and building partnerships with vaccine manufacturing organizations in emerging markets. She began her career as a management consultant for Accenture and Deloitte Consulting.

Rachel earned a BA in Business Administration from the University of Washington and an MBA from Pepperdine University.